Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 (IPI00028098) that score above 1.0

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
CCND1 CDK4 CDK4: Cell division protein kinase 4 45.90 Evidence O
CCND1 STK4 STK4, MST1: Serine/threonine-protein kinase 4 40.50 Evidence
CCND1 CDKN1A CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi 26.40 Evidence O
CCND1 FOXM1 FOXM1, FKHL16, HFH11, MPP2, WIN: Forkhead box protein M1 22.90 Evidence
CCND1 RBL1 RBL1: Retinoblastoma-like protein 1 20.50 Evidence
CCND1 RB1 RB1: Retinoblastoma-associated protein 18.10 Evidence O
CCND1 MCM2 MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 15.30 Evidence
CCND1 CDKN1B CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B 13.50 Evidence O
CCND1 PRKCI PRKCI, DXS1179E: Protein kinase C iota type 13.40 Evidence
CCND1 BRCA1 BRCA1, RNF53: Breast cancer type 1 susceptibility protein 13.2 Evidence O
CCND1 DYRK1A DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin 11.50 Evidence
CCND1 CEBPA CEBPA: CCAAT/enhancer-binding protein alpha 8.63 Evidence
CCND1 CDC7 CDC7, CDC7L1: Cell division cycle 7-related protein kinase 6.81 Evidence
CCND1 BARD1 BARD1: BRCA1-associated RING domain protein 1 6.81 Evidence
CCND1 HDAC2 HDAC2: Histone deacetylase 2 6.66 Evidence
CCND1 HDAC1 HDAC1, RPD3L1: Histone deacetylase 1 5.86 Evidence
CCND1 ZBTB16 ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 5.07 Evidence
CCND1 ATAD2 ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 4.02 Evidence
CCND1 PTBP1 PTBP1: Polypyrimidine tract binding protein 1 3.88 Evidence
CCND1 UNG N/A 3.20 Evidence
CCND1 CHAF1B CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B 3.20 Evidence
CCND1 LCK LCK: Proto-oncogene tyrosine-protein kinase LCK 3.14 Evidence
CCND1 NR1H2 NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta 2.81 Evidence
CCND1 FLT3 FLT3, STK1: FL cytokine receptor precursor 2.75 Evidence
CCND1 TGFBR1 TGFBR1: TGF-beta receptor type-1 precursor 2.69 Evidence
CCND1 MSH6 MSH6, GTBP: DNA mismatch repair protein MSH6 2.59 Evidence
CCND1 ANKS1A ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A 2.59 Evidence
CCND1 LIG1 LIG1: DNA ligase 1 2.59 Evidence
CCND1 TIAM1 TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 2.28 Evidence
CCND1 SEC13L1 N/A 2.28 Evidence
CCND1 SMAD3 SMAD3, MADH3: Mothers against decapentaplegic homolog 3 2.23 Evidence
CCND1 PTMA N/A 2.19 Evidence
CCND1 CCND2 CCND2: G1/S-specific cyclin-D2 2.18 Evidence
CCND1 CCND3 CCND3: G1/S-specific cyclin-D3 2.18 Evidence
CCND1 CCNA2 CCNA2, CCN1, CCNA: Cyclin-A2 2.13 Evidence
CCND1 SMAD2 SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 1.96 Evidence
CCND1 BIN1 BIN1, AMPHL: Myc box-dependent-interacting protein 1 1.53 Evidence
CCND1 BIRC5 BIRC5, API4, IAP4: Baculoviral IAP repeat-containing protein 5 1.48 Evidence
CCND1 IFI35 N/A 1.30 Evidence
CCND1 GMIP GMIP: GEM-interacting protein 1.17 Evidence
CCND1 CHTF18 RUVBL, CHTF18: Protein CTF18 homolog. 1.16 Evidence